2023-15246. Office of the Director; Notice of Charter Renewal

In accordance with Title 41 of the U.S. Code of Federal Regulations, section 102–3.65(a), notice is hereby given that the Charter for the Novel and Exceptional Technology and Research Advisory Committee, was renewed for an additional two-year period on June 30, 2023. It is determined that the Novel and Exceptional Technology Research Advisory Committee is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group.

Inquires may be directed to Claire Harris, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 100, Bethesda, Maryland 20892 (Mail code 4875), Telephone [phone], or [e-mail].

Dated: July 13, 2023.

Victoria E. Townsend,

Program Analyst, Office of Federal Advisory Committee Policy.